1-6 of 6
Frida Bugge Askeland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimizing lenalidomide therapy in renal impairment: Analysis of renal response in the prospective remnant study in transplant-eligible newly diagnosed multiple myeloma

Free
Frida Bugge Askeland, Vilhelm Hauge Bugge, Anne-Marie Rasmussen, Anna Lysén, Einar Haukås, Magnus Moksnes, Anette L. Eilertsen, Galina Tsykunova, Birgitte Dahl Eiken, Nils Morten Leknes, Jürgen Rolke, Vidar Stavseth, Eivind Samstad, Randi Fykse Hallstensen, Damian Szatkowski, Ariane Aasbø Hansen, Anita Smith Nilsen, Tobias S. Slørdahl, Pegah Abdollahi, Fredrik Schjesvold
Journal: Blood
Blood (2025) 146 (Supplement 1): 4032.
https://doi.org/10.1182/blood-2025-4032
Published: 2025
Journal Articles

Steroid-toxicity in newly diagnosed patients with multiple myeloma treated with a limited dexamethasone regimen; Results from the nmsg rest study

Free
Lene Kongsgaard Nielsen, Tine Rosenberg, Andreas Kristian Pedersen, Claudia Routherford, Tracy King, Mararet-Ann Tait, Einar Haukaas, Tobias S. Slørdahl, Anja Klostergaard, Emil Hermansen, Fredrik Schjesvold, Frida Bugge Askeland
Journal: Blood
Blood (2025) 146 (Supplement 1): 2785.
https://doi.org/10.1182/blood-2025-2785
Published: 2025
Journal Articles

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide and dexamethasone (VRd) in patients with newly diagnosed multiple myeloma (NDMM) – interim results from the randomized Phase III COBRA trial.

Free
Dominik Dytfeld, Tadeusz Kubicki, Agata Tyczynska, Marcin Rymko, Krzysztof Jamroziak, Fredrik Schjesvold, Jaroslaw Piszcz, Tomasz Wrobel, Krzysztof Giannopoulos, Bartosz Pula, Agnieszka Konska, Pawel Steckiewicz, Juha Lievonen, Mateusz Ziarkiewicz, Pawel Bernatowicz, Lidia Gil, Anna Lojko-Dankowska, Magdalena Matuszak, Jan Zaucha, Maria Czyzewska, Kamil Wisniewski, Magdalena Olszewska-Szopa, Anna Pula, Frank Wen, Frida Bugge Askeland, Valdas Peceliunas, Jennifer Cooperrider, Ken Jiang, Theodore Karrison, Benjamin Derman, Andrzej Jakubowiak
Journal: Blood
Blood (2025) 146 (Supplement 1): 99.
https://doi.org/10.1182/blood-2025-99
Published: 2025
Journal Articles

Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study

Free
Frida Bugge Askeland, Anne-Marie Rasmussen, Anna Lysen, Einar Haukås, Anette Løken Eilertsen, Magnus Moksnes, Galina Tsykunova, Anders Vik, Birgitte Dahl Eiken, Vidar Stavseth, Jürgen Rolke, Eivind Ottersen Samstad, Valdas Peceliunas, Randi Fykse Hallstensen, Ariane Aasbø Hansen, Anita Smith Nilsen, Tobias S. Slørdahl, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 4755.
https://doi.org/10.1182/blood-2023-189022
Published: 2023
Journal Articles

Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

Free
Frida Bugge Askeland, Einar Haukås, Tobias S. Slørdahl, Anja Klostergaard, Tatjana Alexandersen, Diana Schjøll, Anna Lysen, Emil Hermansen, Fredrik Schjesvold
Journal: Blood
Blood (2023) 142 (Supplement 1): 3381.
https://doi.org/10.1182/blood-2023-173126
Published: 2023
Journal Articles

Relapse from MRD Negativity As Indication for Treatment in Multiple Myeloma - the Remnant Study

Free
Frida Bugge Askeland, MD, Anne-Marie Rasmussen, PhD, Fredrik Schjesvold, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-139230
Published: 2020